世界の耳鼻咽喉科疾患治療市場規模・現状・予測2021-2027

【英語タイトル】Global ENT Disorder Treatment Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR2192)・商品コード:QY21APR2192
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:92
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品、ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、耳鼻咽喉科疾患治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(扁桃炎、耳感染症、副鼻腔感染症、睡眠時無呼吸)、用途別市場規模(病院、診療所、外来手術センター、在宅ケア施設、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・耳鼻咽喉科疾患治療の市場動向
・企業の競争状況、市場シェア
・耳鼻咽喉科疾患治療の種類別市場規模(扁桃炎、耳感染症、副鼻腔感染症、睡眠時無呼吸)
・耳鼻咽喉科疾患治療の用途別市場規模(病院、診療所、外来手術センター、在宅ケア施設、その他)
・耳鼻咽喉科疾患治療の北米市場規模2016-2027(アメリカ、カナダ)
・耳鼻咽喉科疾患治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・耳鼻咽喉科疾患治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・耳鼻咽喉科疾患治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・耳鼻咽喉科疾患治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AstraZeneca、Novartis、Pfizer、Mylan、Teva Pharmaceutical、GlaxoSmithKline、Otonomy、Merck、Reddy’s、Allergen)
・結論
【レポートの概要】

ENT is a medical abbreviation for ears, nose and throat.
Major factor contributing to growth of the global ENT disorder treatment market includes increasing pollution.

Market Analysis and Insights: Global ENT Disorder Treatment Market
The global ENT Disorder Treatment market size is projected to reach US$ 8306.9 million by 2026, from US$ 6930.3 million in 2019, at a CAGR of 2.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global ENT Disorder Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global ENT Disorder Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global ENT Disorder Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global ENT Disorder Treatment market.

Global ENT Disorder Treatment Scope and Market Size
ENT Disorder Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global ENT Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tonsillitis
Ear Infections
Sinus Infections
Sleep Apnea

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Novartis
Pfizer
Mylan
Teva Pharmaceutical
GlaxoSmithKline
Otonomy
Merck
Reddy’s

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ENT Disorder Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tonsillitis
1.2.3 Ear Infections
1.2.4 Sinus Infections
1.2.5 Sleep Apnea
1.3 Market by Application
1.3.1 Global ENT Disorder Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Home Care Settings
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global ENT Disorder Treatment Market Perspective (2016-2027)
2.2 ENT Disorder Treatment Growth Trends by Regions
2.2.1 ENT Disorder Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 ENT Disorder Treatment Historic Market Share by Regions (2016-2021)
2.2.3 ENT Disorder Treatment Forecasted Market Size by Regions (2022-2027)
2.3 ENT Disorder Treatment Industry Dynamic
2.3.1 ENT Disorder Treatment Market Trends
2.3.2 ENT Disorder Treatment Market Drivers
2.3.3 ENT Disorder Treatment Market Challenges
2.3.4 ENT Disorder Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top ENT Disorder Treatment Players by Revenue
3.1.1 Global Top ENT Disorder Treatment Players by Revenue (2016-2021)
3.1.2 Global ENT Disorder Treatment Revenue Market Share by Players (2016-2021)
3.2 Global ENT Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by ENT Disorder Treatment Revenue
3.4 Global ENT Disorder Treatment Market Concentration Ratio
3.4.1 Global ENT Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ENT Disorder Treatment Revenue in 2020
3.5 ENT Disorder Treatment Key Players Head office and Area Served
3.6 Key Players ENT Disorder Treatment Product Solution and Service
3.7 Date of Enter into ENT Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 ENT Disorder Treatment Breakdown Data by Type
4.1 Global ENT Disorder Treatment Historic Market Size by Type (2016-2021)
4.2 Global ENT Disorder Treatment Forecasted Market Size by Type (2022-2027)

5 ENT Disorder Treatment Breakdown Data by Application
5.1 Global ENT Disorder Treatment Historic Market Size by Application (2016-2021)
5.2 Global ENT Disorder Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America ENT Disorder Treatment Market Size (2016-2027)
6.2 North America ENT Disorder Treatment Market Size by Type
6.2.1 North America ENT Disorder Treatment Market Size by Type (2016-2021)
6.2.2 North America ENT Disorder Treatment Market Size by Type (2022-2027)
6.2.3 North America ENT Disorder Treatment Market Size by Type (2016-2027)
6.3 North America ENT Disorder Treatment Market Size by Application
6.3.1 North America ENT Disorder Treatment Market Size by Application (2016-2021)
6.3.2 North America ENT Disorder Treatment Market Size by Application (2022-2027)
6.3.3 North America ENT Disorder Treatment Market Size by Application (2016-2027)
6.4 North America ENT Disorder Treatment Market Size by Country
6.4.1 North America ENT Disorder Treatment Market Size by Country (2016-2021)
6.4.2 North America ENT Disorder Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe ENT Disorder Treatment Market Size (2016-2027)
7.2 Europe ENT Disorder Treatment Market Size by Type
7.2.1 Europe ENT Disorder Treatment Market Size by Type (2016-2021)
7.2.2 Europe ENT Disorder Treatment Market Size by Type (2022-2027)
7.2.3 Europe ENT Disorder Treatment Market Size by Type (2016-2027)
7.3 Europe ENT Disorder Treatment Market Size by Application
7.3.1 Europe ENT Disorder Treatment Market Size by Application (2016-2021)
7.3.2 Europe ENT Disorder Treatment Market Size by Application (2022-2027)
7.3.3 Europe ENT Disorder Treatment Market Size by Application (2016-2027)
7.4 Europe ENT Disorder Treatment Market Size by Country
7.4.1 Europe ENT Disorder Treatment Market Size by Country (2016-2021)
7.4.2 Europe ENT Disorder Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific ENT Disorder Treatment Market Size (2016-2027)
8.2 Asia-Pacific ENT Disorder Treatment Market Size by Type
8.2.1 Asia-Pacific ENT Disorder Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific ENT Disorder Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific ENT Disorder Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific ENT Disorder Treatment Market Size by Application
8.3.1 Asia-Pacific ENT Disorder Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific ENT Disorder Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific ENT Disorder Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific ENT Disorder Treatment Market Size by Region
8.4.1 Asia-Pacific ENT Disorder Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific ENT Disorder Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America ENT Disorder Treatment Market Size (2016-2027)
9.2 Latin America ENT Disorder Treatment Market Size by Type
9.2.1 Latin America ENT Disorder Treatment Market Size by Type (2016-2021)
9.2.2 Latin America ENT Disorder Treatment Market Size by Type (2022-2027)
9.2.3 Latin America ENT Disorder Treatment Market Size by Type (2016-2027)
9.3 Latin America ENT Disorder Treatment Market Size by Application
9.3.1 Latin America ENT Disorder Treatment Market Size by Application (2016-2021)
9.3.2 Latin America ENT Disorder Treatment Market Size by Application (2022-2027)
9.3.3 Latin America ENT Disorder Treatment Market Size by Application (2016-2027)
9.4 Latin America ENT Disorder Treatment Market Size by Country
9.4.1 Latin America ENT Disorder Treatment Market Size by Country (2016-2021)
9.4.2 Latin America ENT Disorder Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa ENT Disorder Treatment Market Size (2016-2027)
10.2 Middle East & Africa ENT Disorder Treatment Market Size by Type
10.2.1 Middle East & Africa ENT Disorder Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa ENT Disorder Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa ENT Disorder Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa ENT Disorder Treatment Market Size by Application
10.3.1 Middle East & Africa ENT Disorder Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa ENT Disorder Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa ENT Disorder Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa ENT Disorder Treatment Market Size by Country
10.4.1 Middle East & Africa ENT Disorder Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa ENT Disorder Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca ENT Disorder Treatment Introduction
11.1.4 AstraZeneca Revenue in ENT Disorder Treatment Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis ENT Disorder Treatment Introduction
11.2.4 Novartis Revenue in ENT Disorder Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer ENT Disorder Treatment Introduction
11.3.4 Pfizer Revenue in ENT Disorder Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan ENT Disorder Treatment Introduction
11.4.4 Mylan Revenue in ENT Disorder Treatment Business (2016-2021)
11.4.5 Mylan Recent Development
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Details
11.5.2 Teva Pharmaceutical Business Overview
11.5.3 Teva Pharmaceutical ENT Disorder Treatment Introduction
11.5.4 Teva Pharmaceutical Revenue in ENT Disorder Treatment Business (2016-2021)
11.5.5 Teva Pharmaceutical Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline ENT Disorder Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in ENT Disorder Treatment Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Otonomy
11.7.1 Otonomy Company Details
11.7.2 Otonomy Business Overview
11.7.3 Otonomy ENT Disorder Treatment Introduction
11.7.4 Otonomy Revenue in ENT Disorder Treatment Business (2016-2021)
11.7.5 Otonomy Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck ENT Disorder Treatment Introduction
11.8.4 Merck Revenue in ENT Disorder Treatment Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Reddy’s
11.9.1 Reddy’s Company Details
11.9.2 Reddy’s Business Overview
11.9.3 Reddy’s ENT Disorder Treatment Introduction
11.9.4 Reddy’s Revenue in ENT Disorder Treatment Business (2016-2021)
11.9.5 Reddy’s Recent Development
11.10 Allergen
11.10.1 Allergen Company Details
11.10.2 Allergen Business Overview
11.10.3 Allergen ENT Disorder Treatment Introduction
11.10.4 Allergen Revenue in ENT Disorder Treatment Business (2016-2021)
11.10.5 Allergen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global ENT Disorder Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tonsillitis
Table 3. Key Players of Ear Infections
Table 4. Key Players of Sinus Infections
Table 5. Key Players of Sleep Apnea
Table 6. Global ENT Disorder Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global ENT Disorder Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global ENT Disorder Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global ENT Disorder Treatment Market Share by Regions (2016-2021)
Table 10. Global ENT Disorder Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global ENT Disorder Treatment Market Share by Regions (2022-2027)
Table 12. ENT Disorder Treatment Market Trends
Table 13. ENT Disorder Treatment Market Drivers
Table 14. ENT Disorder Treatment Market Challenges
Table 15. ENT Disorder Treatment Market Restraints
Table 16. Global ENT Disorder Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global ENT Disorder Treatment Market Share by Players (2016-2021)
Table 18. Global Top ENT Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ENT Disorder Treatment as of 2020)
Table 19. Ranking of Global Top ENT Disorder Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by ENT Disorder Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players ENT Disorder Treatment Product Solution and Service
Table 23. Date of Enter into ENT Disorder Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global ENT Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global ENT Disorder Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global ENT Disorder Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global ENT Disorder Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global ENT Disorder Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global ENT Disorder Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global ENT Disorder Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global ENT Disorder Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America ENT Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America ENT Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America ENT Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America ENT Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America ENT Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America ENT Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe ENT Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe ENT Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe ENT Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe ENT Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe ENT Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe ENT Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific ENT Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific ENT Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific ENT Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific ENT Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific ENT Disorder Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific ENT Disorder Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America ENT Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America ENT Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America ENT Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America ENT Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America ENT Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America ENT Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa ENT Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa ENT Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa ENT Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa ENT Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa ENT Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa ENT Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca ENT Disorder Treatment Product
Table 66. AstraZeneca Revenue in ENT Disorder Treatment Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis ENT Disorder Treatment Product
Table 71. Novartis Revenue in ENT Disorder Treatment Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer ENT Disorder Treatment Product
Table 76. Pfizer Revenue in ENT Disorder Treatment Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Mylan Company Details
Table 79. Mylan Business Overview
Table 80. Mylan ENT Disorder Treatment Product
Table 81. Mylan Revenue in ENT Disorder Treatment Business (2016-2021) & (US$ Million)
Table 82. Mylan Recent Development
Table 83. Teva Pharmaceutical Company Details
Table 84. Teva Pharmaceutical Business Overview
Table 85. Teva Pharmaceutical ENT Disorder Treatment Product
Table 86. Teva Pharmaceutical Revenue in ENT Disorder Treatment Business (2016-2021) & (US$ Million)
Table 87. Teva Pharmaceutical Recent Development
Table 88. GlaxoSmithKline Company Details
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline ENT Disorder Treatment Product
Table 91. GlaxoSmithKline Revenue in ENT Disorder Treatment Business (2016-2021) & (US$ Million)
Table 92. GlaxoSmithKline Recent Development
Table 93. Otonomy Company Details
Table 94. Otonomy Business Overview
Table 95. Otonomy ENT Disorder Treatment Product
Table 96. Otonomy Revenue in ENT Disorder Treatment Business (2016-2021) & (US$ Million)
Table 97. Otonomy Recent Development
Table 98. Merck Company Details
Table 99. Merck Business Overview
Table 100. Merck Revenue in ENT Disorder Treatment Business (2016-2021) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Reddy’s Company Details
Table 103. Reddy’s Business Overview
Table 104. Reddy’s ENT Disorder Treatment Product
Table 105. Reddy’s Revenue in ENT Disorder Treatment Business (2016-2021) & (US$ Million)
Table 106. Reddy’s Recent Development
Table 107. Allergen Company Details
Table 108. Allergen Business Overview
Table 109. Allergen ENT Disorder Treatment Product
Table 110. Allergen Revenue in ENT Disorder Treatment Business (2016-2021) & (US$ Million)
Table 111. Allergen Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ENT Disorder Treatment Market Share by Type: 2020 VS 2027
Figure 2. Tonsillitis Features
Figure 3. Ear Infections Features
Figure 4. Sinus Infections Features
Figure 5. Sleep Apnea Features
Figure 6. Global ENT Disorder Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Home Care Settings Case Studies
Figure 11. Others Case Studies
Figure 12. ENT Disorder Treatment Report Years Considered
Figure 13. Global ENT Disorder Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global ENT Disorder Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global ENT Disorder Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global ENT Disorder Treatment Market Share by Regions (2022-2027)
Figure 17. Global ENT Disorder Treatment Market Share by Players in 2020
Figure 18. Global Top ENT Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ENT Disorder Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by ENT Disorder Treatment Revenue in 2020
Figure 20. Global ENT Disorder Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global ENT Disorder Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America ENT Disorder Treatment Market Share by Type (2016-2027)
Figure 24. North America ENT Disorder Treatment Market Share by Application (2016-2027)
Figure 25. North America ENT Disorder Treatment Market Share by Country (2016-2027)
Figure 26. United States ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe ENT Disorder Treatment Market Share by Type (2016-2027)
Figure 30. Europe ENT Disorder Treatment Market Share by Application (2016-2027)
Figure 31. Europe ENT Disorder Treatment Market Share by Country (2016-2027)
Figure 32. Germany ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific ENT Disorder Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific ENT Disorder Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific ENT Disorder Treatment Market Share by Region (2016-2027)
Figure 42. China ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America ENT Disorder Treatment Market Share by Type (2016-2027)
Figure 50. Latin America ENT Disorder Treatment Market Share by Application (2016-2027)
Figure 51. Latin America ENT Disorder Treatment Market Share by Country (2016-2027)
Figure 52. Mexico ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa ENT Disorder Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa ENT Disorder Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa ENT Disorder Treatment Market Share by Country (2016-2027)
Figure 58. Turkey ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE ENT Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AstraZeneca Revenue Growth Rate in ENT Disorder Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in ENT Disorder Treatment Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in ENT Disorder Treatment Business (2016-2021)
Figure 64. Mylan Revenue Growth Rate in ENT Disorder Treatment Business (2016-2021)
Figure 65. Teva Pharmaceutical Revenue Growth Rate in ENT Disorder Treatment Business (2016-2021)
Figure 66. GlaxoSmithKline Revenue Growth Rate in ENT Disorder Treatment Business (2016-2021)
Figure 67. Otonomy Revenue Growth Rate in ENT Disorder Treatment Business (2016-2021)
Figure 68. Merck Revenue Growth Rate in ENT Disorder Treatment Business (2016-2021)
Figure 69. Reddy’s Revenue Growth Rate in ENT Disorder Treatment Business (2016-2021)
Figure 70. Allergen Revenue Growth Rate in ENT Disorder Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed


【掲載企業】

AstraZeneca、Novartis、Pfizer、Mylan、Teva Pharmaceutical、GlaxoSmithKline、Otonomy、Merck、Reddy’s、Allergen

★調査レポート[世界の耳鼻咽喉科疾患治療市場規模・現状・予測2021-2027] (コード:QY21APR2192)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の耳鼻咽喉科疾患治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆